Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease
- PMID: 31937400
- DOI: 10.1016/j.cgh.2019.05.034
Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease
Comment in
-
Reply.Clin Gastroenterol Hepatol. 2020 Feb;18(2):523-524. doi: 10.1016/j.cgh.2019.07.041. Epub 2019 Jul 25. Clin Gastroenterol Hepatol. 2020. PMID: 31352095 No abstract available.
Comment on
-
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.Clin Gastroenterol Hepatol. 2019 Dec;17(13):2776-2784.e4. doi: 10.1016/j.cgh.2019.04.061. Epub 2019 May 9. Clin Gastroenterol Hepatol. 2019. PMID: 31077838 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical